SEC Comment Letter 0000000000-23-001216 to G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
Date: Feb. 6, 2023 · CIK: 0001760764 · Accession: 0000000000-23-001216
AI Filing Summary & Sentiment
File numbers found in text: 333-269496
Letter
United States securities and exchange commission logo February 6, 2023 Yacov Geva Chief Executive Officer G Medical Innovations Holdings Ltd. 5 Oppenheimer St. Rehovot 7670105, Israel Re:G Medical Innovations Holdings Ltd. Registration Statement on Form F-1 Filed February 1, 2023 File No. 333-269496 Dear Yacov Geva: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Oded Har-Even
Show Raw Text
United States securities and exchange commission logo
February 6, 2023
Yacov Geva
Chief Executive Officer
G Medical Innovations Holdings Ltd.
5 Oppenheimer St.
Rehovot 7670105, Israel
Re:G Medical Innovations Holdings Ltd.
Registration Statement on Form F-1
Filed February 1, 2023
File No. 333-269496
Dear Yacov Geva:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Oded Har-Even